Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Hypoxia Predict Radiation/Surgical Tumor Response/A Correlative Trial of EF5, an Agent for the Detection of Tumor Hypoxia

NCT00896961 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00896961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00896961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Hypoxia Predict Radiation/Surgical Tumor Response/A Correlative Trial of EF5, an Agent for the Detection of Tumor Hypoxia
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2001
Completion date
Not reported
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i adult soft tissue sarcoma, stage i squamous cell carcinoma of the lip and oral cavity, stage ii adult soft tissue sarcoma, stage ii squamous cell carcinoma of the lip and oral cavity, stage iii adult soft tissue sarcoma, stage iii squamous cell carcinoma of the lip and oral cavity